An acoustic neuroma is a tumor that grows from the nerves responsible for balance and hearing. More accurately called vestibular schwannoma, these tumors grow from the sheath covering the vestibulocochlear nerve. Acoustic neuromas are benign (not cancerous) and usually grow slowly. Over time the tumor can cause gradual hearing loss, ringing in the ear, and dizziness. Because of their slow growth, not all acoustic neuromas need to be treated. Treatment options include observation, surgery, and radiation.
Anatomy of the ear
The ear is our organ of hearing and balance. It consists of three parts: the outer ear, the middle ear, and the inner ear. The middle and inner ear are located deep in the temporal bone of the skull. The vestibulocochlear nerve (eighth cranial nerve) is responsible for relaying hearing and balance signals from the inner ear to the brain.
The outer ear funnels sound down the ear canal to the eardrum, which vibrates three tiny bones called ossicles (malleus, incus, and stapes) in the middle ear (Fig. 1). In turn, the stapes vibrates the oval window of the cochlea in the inner ear. The spiral-shaped cochlea is filled with liquid, which moves in response to vibrations. As the fluid moves, thousands of hair cells are stimulated, sending signals along the cochlear nerve, which are processed as hearing in the brain. Attached to the cochlea are three semicircular canals positioned at right angles to each other. The three canals are able to sense head position and body posture. Electrical signals from the semicircular canals are carried to the brain by the superior and inferior vestibular nerves (responsible for balance). The cochlear and vestibular nerves form a bundle inside the bony internal auditory canal before exiting to reach the brainstem. Inside the canal, the vestibulocochlear nerve lies next to the facial nerve. The facial nerve (seventh cranial nerve) is responsible for moving the muscles of the face. The close relationship of the vestibulocochlear and facial nerves explains why facial weakness can occur when an acoustic neuroma grows. Likewise, facial sensation and feeling is controlled by the trigeminal nerve (fifth cranial nerve) and can be affected by large tumors.
What is an acoustic neuroma?
An acoustic neuroma, or vestibular schwannoma, is a benign, slow-growing tumor that arises from the Schwann cells forming the sheath (covering) of the vestibulocochlear nerve. As the tumor grows, it expands from its origin inside the internal auditory canal out into the space between the brainstem and the temporal bone known as the cerebellopontine angle. The pear-shaped tumor can continue to enlarge, compressing the trigeminal nerve, which is responsible for facial sensation. Eventually, the tumor can compress the brainstem. Acoustic neuromas are classified according to their size as small (less than 1.5 cm), medium (1.5 to 2.5 cm), or large (more than 2.5 cm) (Fig. 2).
What are the symptoms?
The symptoms caused by an acoustic neuroma follow the size and growth of the tumor. The most common first symptom is hearing loss in the affected ear, which often goes unrecognized or is mistaken for a normal change of aging. Small tumors, which are typically limited to the bony canal, cause hearing loss in one ear, tinnitus (ringing in the ears), and unsteadiness or dizziness. As the tumor expands into the cerebellopontine angle, hearing loss may worsen, facial weakness may occur, and balance problems (disequilibrium) may occur. Large tumors can compress the brainstem (causing imbalance) and the trigeminal nerve (causing facial numbness). As brainstem compression becomes severe, the fourth ventricle collapses and hydrocephalus results, causing persistent headache and visual problems.
What are the causes?
The cause of acoustic neuromas is largely unknown. No environmental factor (such as cell phones or diet) has been scientifically proven to cause these tumors. They can be sporadic or caused by an inherited condition called neurofibromatosis type 2 (NF-2). Sporadic tumors occur 95% of the time, while 5% of acoustic tumors are caused by NF-2.
Neurofibromatosis is a rare disease that occurs in two forms. Type 1 causes tumors to grow on nerves throughout the body, especially the skin. Type 2 can cause acoustic tumors on both left and right sides, creating the possibility of complete deafness if the tumors grow unchecked. The presence of bilateral acoustic tumors affects the choice of treatment, as hearing preservation is a prime objective.
Who is affected?
Acoustic neuromas affect about 10 people in one million. More women than men are affected. Patients usually are diagnosed between 30 to 60 years of age.
How is a diagnosis made?
The doctor will ask about your personal and family medical history and will perform a complete physical examination. In addition to checking your general health, the doctor will perform a neurological exam. This will include checks for mental status and memory, cranial nerve function (sight, hearing, smell, tongue and facial movement), muscle strength, coordination, reflexes, and response to pain. Diagnostic tests may include:
Audiogram is a hearing test performed by an audiologist. During the test you will wear earphones and hear a range of sounds at different tones directed to one ear at a time. Also, speech discrimination will be assessed. The test can detect whether you have hearing loss that is sensorineural (from nerve damage) or conductive (from eardrum or ossicle damage).
Electronystagmography (ENG) is a test that evaluates your balance by detecting eye movements while stressing your balance in various ways. During ENG, eye movements are recorded with small electrodes placed on the skin around the eyes. Alternatively, eye movements may be recorded by videonystagmography (VNG), using an infrared video camera mounted inside goggles that you wear.
Magnetic Resonance Imaging (MRI) is a noninvasive test that uses a magnetic field and radiofrequency waves to give a detailed view of the soft tissues of the brain. A contrast agent called gadolinium may be injected into the bloodstream during scanning to make tumors more visible. MRI is useful in evaluating lesions and their effects on surrounding brain structures (Fig. 2).
Computed Tomography (CT) is a noninvasive test that uses X-rays and a computer to view anatomical structures within the brain. It is especially useful for viewing changes in bony structures such as widening of the internal auditory canal.
Auditory Brainstem Response (ABR) is a test that checks the hearing pathway to the brainstem. Electrodes on the scalp and earlobes capture the brain's responses to clicking noises heard through earphones.
What treatments are available?
The treatment that is right for you will depend on your age, general health, hearing status, and the tumor size. The larger the tumor, the more complex the treatment. Therefore, early recognition, diagnosis, and treatment are essential. Because each patient and acoustic neuroma differs, it is important to seek treatment at a medical center that offers the full range of options including surgery, radiation, and hearing or facial rehabilitation. A neurosurgeon, otologic surgeon, and radiation oncologist work as a team to treat acoustic tumors.
Observation (growth monitoring)
Acoustic tumors that are small and have few symptoms may be observed with MRI scans every year until tumor growth or symptoms change. The average acoustic neuroma growth rate is 1.15 to 2.4 mm per year. In 10 to 20% of observed patients, tumor changes require surgery or radiation treatment . Observation may be the best option for older patients with other health conditions or patients with a tumor in their only hearing ear.
Surgical removal is the most common treatment for acoustic neuromas, especially large ones. Priorities in surgery are: first, the maintenance of facial nerve function; second, the preservation of socially useful hearing in the affected ear; and third, complete tumor removal. While total tumor removal may result in a cure, it also carries a higher risk of hearing and facial nerve damage. During tumor removal, a probe is used to stimulate and monitor the cranial nerves and brainstem function. Because acoustic tumors grow slowly, new research supports partial or near-total removal, whereby small remnants of tumor capsule are left attached to critical nerves . Tumor recurrence is essentially the same with total and near-total removal, but facial nerve damage is significantly reduced with near-total. If the tumor remnant grows, radiation may be used.
There are several surgical approaches to opening the skull (craniotomy) and removing the tumor (Fig. 3). The choice of a particular approach depends on the tumor size, tumor position, and hearing status.
- Suboccipital (retrosigmoid) craniotomy is made behind the ear in the occipital bone. Bone overlying the internal auditory canal is removed to expose and remove the tumor. This approach may be used for all tumor sizes, but especially large ones, while preserving facial nerve function and useful hearing if possible.
- Translabyrinthine craniotomy is made through the ear in the mastoid bone. The semicircular canals are removed to expose the tumor in the internal auditory canal. Because the canals are removed, complete hearing loss occurs in the affected ear. This approach may be used for patients who already have hearing loss or when preservation of hearing is not possible.
- Middle fossa craniotomy is made above the ear in the temporal bone. Bone overlying the internal auditory canal is removed to expose and remove the tumor. This approach may be used for small tumors and when preservation of hearing is optimal.
Outcomes of surgery depend on the size and adherence of the tumor, the use of cranial nerve monitoring, and the skill of the surgical team. The Acoustic Neuroma Association reports 60% of members have acceptable facial function after surgery. The medical literature reports vary, but overall, facial movement is preserved in 75% and useful hearing is preserved in 20% of patients [3,4]. Delayed hearing loss may occur after surgery in 30 to 50% of patients who had useful hearing immediately after surgery. Partial-removal techniques have higher rates of hearing and facial function preservation; however, the long-term results of these techniques are still being investigated.
Complications of surgery may include facial weakness or paralysis, cerebrospinal fluid leak, persistent headache, meningitis, and stroke. Tumor recurrence is less than 5% after surgical removal.
The goal of radiation treatment is to stop or control tumor growth. It does not remove the tumor. Radiation is used to treat small and medium-sized acoustic neuromas (<2.5 cm). Using controlled high-energy rays, radiation works by damaging the DNA inside cells and making them unable to divide and reproduce. The aim of radiation therapy is to maximize the dose to abnormal cells and minimize exposure to normal cells (Fig. 4). The benefits of radiation are not immediate but occur over time. Gradually, the tumor stops growing and in some cases may shrink in size. Periodic MRI scans are necessary throughout your lifetime to monitor for tumor changes. There are two ways to deliver radiation:
- Fractionated stereotactic radiotherapy (FSR) delivers a low dose of radiation over multiple visits. A face mask is used to precisely locate the tumor and accurately reposition the patient for each treatment session. Patients return daily over 5 to 7 weeks to receive the complete radiation dose. Recent studies have shown that patients treated with FSR may experience better hearing preservation than those treated with stereotactic radiosurgery .
- Stereotactic radiosurgery (SRS) delivers a high dose of radiation during a single session. Although it is called surgery, no incision is made. Because a single radiosurgery dose is more damaging than multiple fractionated doses, the target area must be precisely located and completely immobilized with a stereotactic head frame or mask. Patients spend most of the day at the center while the tumor is precisely located, a treatment plan is developed, and a radiation dose is delivered.
In general, there are two types of radiation-delivery machines: the Gamma Knife and LINAC. The Gamma Knife resembles a helmet that surrounds the patient's head. It targets 201 individual beams of radiation on the tumor. Each beam travels through a different area of the brain. Where the beams intersect, they damage the tumor. The other type of radiation-delivery machine, the LINAC (linear accelerator), rotates around the patient’s head while producing multiple beams of radiation that arc toward the target on the tumor. Where the beams converge, they damage the tumor.
Published studies of SRS for acoustic neuromas report 93% tumor control, 63% chance of preserving useful hearing and a 4% risk of permanent facial weakness .
Complications after radiation may include hearing loss, facial weakness, facial sensory loss, radiation necrosis, and brainstem injury. There is also a slight risk of radiation-induced malignant tumors years after treatment. Radiation can cause scar tissue to develop around the tumor and facial nerve, making surgical removal more difficult should the tumor grow back.
Clinical trials are research studies in which new treatments—drugs, diagnostics, procedures, and other therapies—are tested in people to see if they are safe and effective. Research is always being conducted to improve the standard of medical care. Information about current clinical trials, including eligibility, protocol, and locations, are found on the Web. Studies can be sponsored by the National Institutes of Health (see clinicaltrials.gov) as well as private industry and pharmaceutical companies (see www.centerwatch.com).
Recovery and prevention
Coping with the possibility of hearing loss and facial paralysis and deciding which treatment is best for you can be difficult. The Acoustic Neuroma Association collects and publishes outcomes data from member surveys on their Web site.
Hearing preservation is an important goal for patients with an acoustic neuroma, although it is not always possible. All treatment options carry a risk of hearing loss. The Gardner-Robertson Scale is used to measure hearing (1=good, 2=serviceable) (Fig. 5). Hearing loss in one ear affects your ability to tell where a sound is coming from. An audiologist or speech therapist can help you learn tips for coping with one-sided deafness. Certain types of hearing aids called CROS (Contralateral Routing of Sound) and BAHA (Bone-Anchored Hearing Aid) may be helpful. These hearing aids take sound that would normally enter the non-hearing ear and route the signal to the hearing ear.
Patients with NF-2 can develop bilateral acoustic neuromas, and most may eventually lose hearing in both ears. All NF-2 patients with bilateral acoustic neuromas should learn sign language before deafness occurs. An auditory brainstem implant (ABI) can be inserted during surgery to provide a sensation of hearing by bypassing the cochlea and directly stimulating the brainstem. The device does not enable the full range of hearing, but it does provide increased noise awareness. Most patients are able to hear noises, such as a ringing telephone, but the degree of hearing usefulness can vary greatly. An auditory brainstem implant, combined with lip reading, helps improve communication.
Balance problems can be improved with exercise, Pilates, or Tai Chi. Dizziness is common and will persist until the opposite ear can compensate and stabilize, usually within 1 to 4 months. Persistent problems with balance, dizziness, or vertigo may require treatment with vestibular rehabilitation.
Facial exercises and massage are recommended to improve facial nerve function. The House-Brackmann Scale is used to evaluate facial nerve function before and after treatment (Fig. 6). If a patient has facial weakness after treatment, eye care consists of artificial tears and lubricant until facial nerve function returns. If a patient has facial paralysis 1 year after surgery, the chance of further recovery is reduced. Consultation with an ENT surgeon who specializes in facial plastic and reconstructive surgery is recommended.
Acoustic neuromas sometimes recur after radiation or surgery. Periodic MRI scans (every 1 to 3 years) and hearing tests are an important part of long-term monitoring.
Sources & links
If you have questions, please contact the Mayfield Clinic at 800-325-7787 or 513-221-1100. For information about the University of Cincinnati Neuroscience Institute’s Brain Tumor Center, call 866-941-8264.
Support groups are available through the Acoustic Neuroma Association; call 770-205-8211.
- Bakkouri WE, et al. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 110:662-669, 2009
- Seol HJ, et al. Optimal extent of resection in vestibular schwannoma surgery: relationship to recurrence and facial nerve preservation. Neurol Med Chir 46:176-180, 2006
- Raftopoulos C, et al. Microsurgical results with large vestibular schwannomas with preservation of facial and cochlear nerve function as primary aim. Acta Neurochir 147:697-706, 2005
- Samii M, et al. Hearing Preservation after Complete Microsurgical Removal in Vestibular Schwannomas. Régis J, Roche P-H (eds): Modern Management of Acoustic Neuroma. Prog Neurol Surg 21:136-141, 2008
- Andrews DW, et al. Toward dose optimization for fractionated radiotherapy for acoustic neuromas: comparison of two dose cohorts. Int J Radiat Oncol Biol Phys 74:419-26, 2009
- Pollock BE, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77-85, 2006
acoustic nerve: the eighth cranial nerve, also known as the vestibulocochlear nerve, is responsible for hearing and balance.
brainstem: connects the upper brain to the spinal cord; responsible for autonomic functions such as breathing and heart rate.
cerebellopontine angle: the space between the cerebellum and pons of the brainstem and the petrous bone.
cerebrospinal fluid: a watery fluid that flows within the ventricles and around the surface of the brain and spinal cord.
craniotomy: a surgical opening in the skull.
disequilibrium: a lack of balance caused by a problem in the vestibular system of the ear.
facial nerve: the seventh cranial nerve, responsible for movement of the face.
facial palsy: paralysis of the facial muscles on one side.
neuroma: tumor originating from nerve cells; also called neurinoma, schwannoma.
neurofibromatosis: an inherited condition that causes tumors to grow on nerves throughout the body. Type 1 (NF-1) tumors grow on or below the skin and in the peripheral nerves. Type 2 (NF-2) tumors grow on spinal and cranial nerves and can cause bilateral acoustic neuromas. Also called von Recklinghausen disease.
radiation necrosis: death of healthy tissue caused by delivery of radiation to kill tumor cells.
tinnitus: ringing or buzzing noise in the ear.
vertigo: a feeling of spinning, whirling or turning.
updated > 2.2013
reviewed by > John Tew, MD, Nancy McMahon, RN, Mayfield Clinic / University of Cincinnati Department of Neurosurgery, Ohio
Mayfield Certified Health Info materials are written and developed by the Mayfield Clinic & Spine Institute. We comply with the HONcode standard for trustworthy health information. This information is not intended to replace the medical advice of your health care provider.
The Mayfield Clinic treats more than 160 patients with acoustic neuroma and neurofibromatosis (NF-2) a year. Our affiliation with the University of Cincinnati Brain Tumor Center and the Precision Radiotherapy Center provides patients with care from a multidisciplinary team of doctors.
We are one of the few acoustic neuroma treatment centers to offer all available treatment options: surgery, radiosurgery, and observation as well as hearing restoration (BAHA, auditory brainstem implant), and balance and facial restoration treatments. Our team has worked together for more than 30 years to provide superior patient care.
The team includes two otolaryngologists, two neurosurgeons, two neurotologists, and two radiation oncologists. Audiologists, rehabilitation specialists and physical therapists are also part of the team. Genetic counseling for NF-2 is available for patients and their families.
Advances in technology give Mayfield’s neurosurgeons unprecedented access to brain tumors. Image-guided systems enable us to navigate precisely in remote areas and to remove tumors with minimum impact to our patients. Intraoperative diagnostics, including the Mayfield MobileSCAN CT and intraoperative MRI, give up-to-date images of an operation and help surgeons confirm that every bit of tumor has been removed. Radiation technologies like Tomotherapy, Trilogy, and Novalis systems allow us to eradicate some tumors without making any incision at all.
To make an appointment, call 513-221-1100.